Building better models: if we build them, will policy makers use them? Toward integrating modeling into health care decisions

scientific article published in September 2012

Building better models: if we build them, will policy makers use them? Toward integrating modeling into health care decisions is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P356DOI10.1177/0272989X12458978
P932PMC publication ID4503228
P698PubMed publication ID22990079
P5875ResearchGate publication ID230879192

P50authorAnn ZauberQ56012057
Jeanne S MandelblattQ90278289
P2093author name stringClyde Schechter
David Levy
Ruth Etzioni
Yaojen Chang
P2860cites workStool DNA testing to screen for colorectal cancer in the Medicare population: a cost-effectiveness analysisQ36627490
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursorsQ36712680
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task ForceQ37318617
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.Q38044578
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.Q39550770
The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services.Q40713076
Economic evaluation in support of national health policy: the case of The NetherlandsQ40886657
Routine human immunodeficiency virus testing: an economic evaluation of current guidelines.Q45504898
The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screeningQ47703987
Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort.Q50675686
More mammography muddle: emotions, politics, science, costs, and polarization.Q50696276
Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.Q50712937
Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.Q50759784
Current HIV epidemiology and revised recommendations for HIV testing in health-care settings.Q51107657
United States Preventive Services Task Force screening mammography recommendations: science ignored.Q51157680
Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.Q52024329
Archimedes: a new model for simulating health care systems--the mathematical formulation.Q52029151
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.Q53123530
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2.Q53123531
From Principle To Public Policy: Using Cost-Effectiveness AnalysisQ57346019
Modeling Using Discrete Event SimulationQ57589510
How much can current interventions reduce colorectal cancer mortality in the U.S.?Q61881610
State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3.Q64990357
Clinical decision making: from theory to practice. Applying cost-effectiveness analysis. The inside storyQ67559921
When evidence collides with anecdote, politics, and emotion: breast cancer screeningQ82907572
Response to Hendrick and Helvie by the Cancer Intervention Surveillance Modeling Network (CISNET) Breast Working GroupQ84975109
Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6Q84992017
Reaching Healthy People 2010 by 2013: A SimSmoke simulationQ33744274
The FDA's regulation of health economic informationQ34036379
Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare populationQ34071763
ACS report on the cancer-related health checkupQ34269117
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harmsQ35013356
Chapter 15: Public health policy and cost-effectiveness analysis.Q35154963
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force reportQ36263674
Computational modeling and multilevel cancer control interventionsQ36352839
The frequency of cervical cancer screening. Comparison of a mathematical model with empirical dataQ36468372
P433issue5
P304page(s)656-659
P577publication date2012-09-01
P1433published inMedical Decision MakingQ6806321
P1476titleBuilding better models: if we build them, will policy makers use them? Toward integrating modeling into health care decisions
P478volume32

Reverse relations

cites work (P2860)
Q38766423Calibrating Parameters for Microsimulation Disease Models: A Review and Comparison of Different Goodness-of-Fit Criteria
Q34171768Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery disease.
Q38412277Health economics and outcomes methods in risk-based decision-making for blood safety
Q36025063The Population Health Model (POHEM): an overview of rationale, methods and applications
Q40735681The Role of Decision Models in Health Care Policy: A Case Study.
Q64082240Using mathematical modeling to inform health policy: A case study from voluntary medical male circumcision scale-up in eastern and southern Africa and proposed framework for success

Search more.